239,438 doses of COVID-19 vaccines, which includes both the AstraZeneca and Sinopharm Vaccines 1st and 2nd doses, have been administered as of Friday last week 5th of November. Meenit Suryadeo Charan, ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Over the course of two decades, China has built a public health aid program for the world, turbocharged by the pandemic. As ...

The Jan. 22 report noted the challenges of distributing vaccines among different communities with varying risk factors.